Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Michigan Business Tribune.
Press releases published on May 23, 2025

Ninepoint Partners Announces May 2025 Cash Distributions for ETF Series Securities
TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (“Ninepoint Partners”) today announced the May 2025 cash distributions for its ETF Series securities. The record date for the distributions is May 30, 2025. All distributions are payable on …

Partenaires Ninepoint annonce les distributions en espèces de mai 2025 pour ses titres de série de FNB
TORONTO, 23 mai 2025 (GLOBE NEWSWIRE) -- Partenaires Ninepoint LP (« Partenaires Ninepoint ») a annoncé aujourd’hui les distributions en espèces de mai 2025 pour ses titres de série de FNB. La date de référence des distributions est le 30 mai 2025. Toutes …

AllDomains Launches .sol Plus: Upgrade Solution That Brings Revenue-Sharing to .sol Domain Owners
New York City, NY, United States, May 23, 2025 (GLOBE NEWSWIRE) -- AllDomains, a leading multi-chain web3 name service provider, has announced the launch of .sol Plus, a new upgrade programme that transforms traditional .sol domains into renewable, revenue …

DBM Global to Pay Cash Dividend
PHOENIX, May 23, 2025 (GLOBE NEWSWIRE) -- DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE Corp. (NYSE: VATE), announced today that it will pay a cash dividend …

Clearwater Properties Agents Receive Top Producer Honors
SEELEY LAKE, Mont., May 23, 2025 (GLOBE NEWSWIRE) -- Clearwater Properties is proud to announce the recipients of its Top Producer Awards for 2024. Each year in April, the regional brokerage awards its top 10 agents and brokers in sales volume for the …

Polyrizon Announces Receipt of Nasdaq Delisting Notice
Raanana, Israel, May 23, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a …

Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
HOUSTON, May 23, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on May 21, 2025, which indicated that the Company was not in compliance with Nasdaq …

Jayud Global Logistics Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
SHENZHEN, China, May 23, 2025 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen, specializing in cross-border logistics, today announced that …

INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of …

Oyster Enterprises II Acquisition Corp Completes Upsized $253,000,000 Initial Public Offering
Miami, Florida, May 23, 2025 (GLOBE NEWSWIRE) -- Oyster Enterprises II Acquisition Corp (the “Company”) (Nasdaq: OYSEU) announced today the closing of its upsized initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant …

Pelican Acquisition Corporation Announces Pricing of $75,000,000 Initial Public Offering
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- Pelican Acquisition Corporation (NASDAQ: PELIU) (the “Company”), a Cayman Islands exempted company, announced that it priced its initial public offering of 7,500,000 units at $10.00 per unit on May 22, 2025. The …

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
IRVINE, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, …

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
PRINCETON, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that …

Middlesex Water Company Board of Directors Names Nadine Leslie Chair and Amy Mansue Lead Director
ISELIN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Middlesex Water Company (NASDAQ:MSEX), a provider of life-sustaining water and wastewater utility services, announced that its Board of Directors has named Nadine Leslie as Chair of the Board. Leslie, who …

Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F
Jilin, China, May 23, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, …

Delisting of Securities from The Nasdaq Stock Market
Delisting of Securities of Bruush Oral Care Inc., IX Acquisition Corp., BAIYU Holdings, Inc., DUET Acquisition Corp., ENGlobal Corporation, Perception Capital Corp. III, Biora Therapeutics, Inc., Akoustis Technologies, Inc., iLearningEngines, Inc., …

QCR Holdings, Inc. Announces Annual Meeting Results and a Cash Dividend of $0.06 Per Share
MOLINE, Ill., May 23, 2025 (GLOBE NEWSWIRE) -- QCR Holdings, Inc. (NASDAQ: QCRH) (the “Company”) today announced the election of three Class II directors at the Company’s annual meeting of its stockholders. The directors, Brent R. Cobb, Mark C. Kilmer, and …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
Faruqi …

Boundless Bio Announces Portfolio Prioritization and Runway Extension
Portfolio prioritization focuses on novel-novel combination therapy of BBI-355 and BBI-825 and new development candidate, BBI-940, for novel kinesin program Operating runway extended into the first half of 2028, through expected proof-of-concept clinical …

Silvercrest Asset Management Group Inc. Announces $25 Million Common Stock Repurchase Program
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) (the “Company” or “Silvercrest”) today announced that the Company's Board of Directors authorized a common stock repurchase program. Under the program, the …